Moyamoya disease: A human model for chronic hypoperfusion and intervention in Alzheimer's disease

Moyamoya disease: A human model for chronic hypoperfusion and intervention in Alzheimer's disease

Abstract Introduction Chronic cerebral hypoperfusion has been considered the etiology for sporadic Alzheimer's disease (AD). However, no valid clinical evidence exists due to the similar risk factors between cerebrovascular disease and AD. Methods We used moyamoya disease (MMD) as a model of ch...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiang Zou, Yifan Yuan, Yujun Liao, Conglin Jiang, Fan Zhao, Ding Ding, Yuxiang Gu, Liang Chen, Ying‐Hua Chu, Yi‐Cheng Hsu, Patrick Alexander Liebig, Bin Xu, Ying Mao
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:	Alzheimer's disease cognitive impairment hypoperfusion metabolism moyamoya disease revascularization
Online Access:	https://doi.org/10.1002/trc2.12285
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cognitive dysfunction in Moyamoya disease: latest developments and future directions
by: Xilong Wang, et al.
Published: (2024-12-01)

Role of scalp arteries in revascularization after side to side anastomosis in moyamoya disease patients
by: Jin Yu, et al.
Published: (2024-12-01)

Low hemoglobin is associated with postoperative cerebral infarction in moyamoya disease: development of a predictive model based on low hemoglobin
by: Haitao Wu, et al.
Published: (2025-01-01)

Introducing an index on prediction of post-revascularization cerebral infarction using preoperative CT perfusion parameters in moyamoya disease
by: Xiaojun Hao, et al.
Published: (2025-01-01)

Coincidence of Concentric Vessel-Wall Contrast Enhancement in Moyamoya Disease and Acute Postoperative Ischemic Stroke During Revascularization Procedures
by: Patrick Haas, et al.
Published: (2024-11-01)

Risk Factors and Characteristics Associated with Visual Impairment and Eye Diseases in Moyamoya Disease: Insights from a National Database
by: Youyi Song, et al.
Published: (2024-11-01)

Multiple burr hole and erythropoietin combination therapy: optimal early surgical intervention for patients with acute stroke episode of moyamoya disease or moyamoya syndrome
by: Yeonhu Lee, et al.
Published: (2024-12-01)

Angiographic features and progression risk factors in children with asymptomatic moyamoya disease
by: Jiyuan Wang, et al.
Published: (2024-11-01)

Research progress in unilateral moyamoya disease
by: Xiaokuan Hao, et al.
Published: (2025-01-01)

Corrigendum: Case Report: A rare presentation of rapidly progressive moyamoya disease refractory to unilateral surgical revascularization
by: Daniel F. Leach, et al.
Published: (2025-01-01)

Increased risk of open angle glaucoma in patients with moyamoya disease from a nationwide population-based cohort in Korea
by: Min Seok Kim, et al.
Published: (2024-12-01)

Case Report: A rare presentation of rapidly progressive moyamoya disease refractory to unilateral surgical revascularization
by: Daniel Friel Leach, et al.
Published: (2024-08-01)

Clinical features and endovascular treatment of ruptured peripheral cerebral aneurysms associated with moyamoya disease: an 8-year single-center experience
by: Zheng Feng, et al.
Published: (2025-12-01)

Moyamoya Disease and Carotid Web in a Young Adult With Ischemic Stroke: A Case Report
by: Sheng Zhuang, et al.
Published: (2024-12-01)

Risk factors for perioperative cerebral infarction in moyamoya disease: a meta-analysis
by: Jincan Wu, et al.
Published: (2025-01-01)

Orofacial features and dental management of a pediatric patient with moyamoya disease—A one year follow up
by: Salma G. Alharbi, et al.
Published: (2024-11-01)

PRESSURE MEASUREMENT IN MOYAMOYA BYPASS SURGERY
by: Bin Xu
Published: (2024-11-01)

Prognostic value of morphology and hemodynamics in moyamoya disease for long-term outcomes and disease progression
by: Long Ma, et al.
Published: (2024-11-01)

Reorganization of gray matter networks in patients with Moyamoya disease
by: Huan Zhu, et al.
Published: (2025-01-01)

Moyamoya disease manifesting with bilateral involvement of the proximal vertebral arteries: A case report
by: Omar Alwakaa, et al.
Published: (2024-12-01)

Analysis of macula structural changes in Moyamoya disease using AI-assisted OCT
by: Xiaochun Li, et al.
Published: (2024-02-01)

Neurologopedic Therapy in a Child with Moyamoya Disease
by: Marta Szlufik, et al.
Published: (2018-06-01)

Associations of Serum Isoleucine with Mild Cognitive Impairment and Alzheimer’s Disease
by: Xiao-jun Jing, et al.
Published: (2024-09-01)

Altered neurovascular coupling and structure-function coupling in Moyamoya disease affect postoperative collateral formation
by: Lingji Jin, et al.
Published: (2024-12-01)

Exploring <i>RNF213</i> in Ischemic Stroke and Moyamoya Disease: From Cellular Models to Clinical Insights
by: Benjamin Y. Q. Tan, et al.
Published: (2024-12-01)

Association of hearing, vision, and dual sensory impairment and risk of Alzheimer’s disease: a nested case-control study
by: Blair Rajamaki, et al.
Published: (2024-11-01)

Incidence and Prevalence of Alzheimer’s Disease in Medicare Beneficiaries
by: Haixin Zhang, et al.
Published: (2024-12-01)

Aging-associated sensory decline and Alzheimer’s disease
by: Suji Hong, et al.
Published: (2024-12-01)

Integrated analysis of chromatin and transcriptomic profiling of the striatum after cerebral hypoperfusion in mice
by: Shijia Le, et al.
Published: (2025-01-01)

The significance of postbypass blood flow model in side to side bypass for moyamoya disease in predicting postoperative cerebral hyperperfusion syndrome
by: Guiping Wan, et al.
Published: (2024-11-01)

Alzheimer’s Disease: Understanding Motor Impairments
by: Jesús Andrade-Guerrero, et al.
Published: (2024-10-01)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
by: Eleonora M. Vromen, et al.
Published: (2022-01-01)

Alzheimer’s disease may develop from changes in the immune system, cell cycle, and protein processing following alterations in ribosome function
by: Akiko Yamakawa, et al.
Published: (2025-01-01)

RETRACTED: Associations of vitamin D receptor polymorphisms with risk of Alzheimer’s disease, Parkinson’s disease, and mild cognitive impairment: a systematic review and meta-analysis
by: Yanjun Du, et al.
Published: (2024-04-01)

Impact of diabetes on the progression of Alzheimer’s disease via trajectories of amyloid–tau–neurodegeneration (ATN) biomarkers
by: Eun Woo Kim, et al.
Published: (2025-02-01)

Differences in cerebral structure among patients with amnestic mild cognitive impairment and patients with Alzheimer’s disease
by: Xiaorui Cui, et al.
Published: (2024-12-01)

Dynamic changes and prognostic value of glutathione S-transferase alpha in mild cognitive impairment and Alzheimer’s disease
by: Yangyang Tang, et al.
Published: (2024-12-01)

Functional and effective EEG connectivity patterns in Alzheimer’s disease and mild cognitive impairment: a systematic review
by: Elizabeth R. Paitel, et al.
Published: (2025-02-01)

Hypoperfusion Intensity Ratio as an Indirect Imaging Surrogate in Patients With Anterior Circulation Large‐Vessel Occlusion and Association of Baseline Characteristics With Poor Collateral Status
by: Omar Hamam, et al.
Published: (2024-08-01)

Impact of Aluminium Chloride (AlCl₃) on Brain Function: A Review of Neurotoxic Mechanisms and Implications for Alzheimer's Disease
by: Amtul Rahman, et al.
Published: (2024-12-01)